Why Thigh Injections Work Well With PlexusDx Semaglutide PlexusDx compounded semaglutide is formulated by licensed 503A compounding pharmacies to match the subcutaneous absorption profile of brand-name Ozempic, meaning thigh injection sites deliver equivalent bioavailability as abdominal or arm sites
Freezing damage bypasses genetic factors altogetherit simply destroys the active compound
doi:10.1016/j.det.2005.05.012 Singh A, D'Amico D, Andreux PA, Fouassier AM, Blanco-Bose W, Evans M, Aebischer P, Auwerx J, Rinsch C
Also see our Top Picks for coconut and MCT oils
In December 2025, the Food and Drug Administration (FDA) approved an oral pill form of Wegovy for weight loss, and in April 2026 approved the once-daily oral GLP-1 drug Foundayo (orforglipron) also for weight loss